Proof-of-concept trial to evaluate the pharmacokinetics of a controlled-release pravastatin formulation [CRES; controlle-release enhanced statin] versus a conventional pravastatin formulation [Pravachol] in volunteers.
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 26 May 2009
At a glance
- Drugs Pravastatin (Primary)
- Indications Dyslipidaemias
- Focus Pharmacokinetics
- 26 May 2009 New trial record.